Alliance Wealth Advisors (Utah)’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
Alliance Wealth Advisors (Utah)'s AMGN Position: Q2 2026 in Review
Alliance Wealth Advisors (Utah) reduced its Amgen (AMGN) stake by 2.8% in Q2 2026, selling an estimated $7.87K and leaving 813 shares worth $294K. The position accounts for 0.06% of the portfolio, ranked #191.
Alliance Wealth Advisors (Utah) first reported a position in AMGN in Q4 2022 and has held it in 5 quarters since. The position peaked at $409K in Q4 2022. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Alliance Wealth Advisors (Utah) held 813 shares of Amgen worth $294K as of Q2 2026.
- Alliance Wealth Advisors (Utah) sold 23 Amgen shares in Q2 2026, an estimated $7.87K.
- Amgen made up 0.06% of Alliance Wealth Advisors (Utah)'s portfolio in Q2 2026, its #191 holding.
- Alliance Wealth Advisors (Utah) first reported a position in Amgen in Q4 2022 and has held it in 5 quarters since.
- Alliance Wealth Advisors (Utah)'s Amgen position peaked at $409K in Q4 2022.
- 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Alliance Wealth Advisors (Utah)'s 13F filing for Q2 2026, filed 23 Jul 2026.